Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewLetrozole is a potent, reversible non-steroidal aromatase inhibitor (IC50 = 11.5 nM). Displays antitumor effects in several animal models. Suppresses the endogenous aromatase-induced proliferation of MCF-7 cells.
Letrozole is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.
M. Wt | 285.3 |
Formula | C17H11N5 |
Storage | Store at +4°C |
Purity | ≥99% (HPLC) |
CAS Number | 112809-51-5 |
PubChem ID | 3902 |
InChI Key | HPJKCIUCZWXJDR-UHFFFAOYSA-N |
Smiles | N#CC(C=C2)=CC=C2C(N3N=CN=C3)C1=CC=C(C#N)C=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 28.53 | 100 |
The following data is based on the product molecular weight 285.3. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 3.51 mL | 17.53 mL | 35.05 mL |
5 mM | 0.7 mL | 3.51 mL | 7.01 mL |
10 mM | 0.35 mL | 1.75 mL | 3.51 mL |
50 mM | 0.07 mL | 0.35 mL | 0.7 mL |
References are publications that support the biological activity of the product.
Mitropoulou et al (2003) Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. Int.J.Cancer 104 155 PMID: 12569569
Bhatnagar et al (1990) Highly selective inhbition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J.Steroid Biochem.Mol.Biol. 37 1021 PMID: 2149502
Bhatnagar (2007) The discovery and mechanism of action of letr. Breast Cancer Res.Treat. 105 7 PMID: 17912633
If you know of a relevant reference for Letrozole, please let us know.
Keywords: Letrozole, Letrozole supplier, CGS20267, non-steroidal, aromatase, CYP19, inhibitors, inhibits, potent, reversible, antitumor, antitumour, CGS, 20267, Cytochrome, P450, Estrogen, and, Related, Receptors, 4382, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Letrozole include:
Tozzi et al (2015) Endogenous 17β-OE is required for activity-dependent long-term potentiation in the striatum: interaction with the DArgic system. Front Cell Neurosci 9 192 PMID: 26074768
Ruiz-Palmero et al (2016) OOE synthesized by female neurons generates sex differences in neuritogenesis. Scientific Reports 6 31891 PMID: 27553191
Xin-Ming et al (2023) Klotho Regulated by Estrogen Plays a Key Role in Sex Differences in Stress Resilience in Rats. Int J Mol Sci 24 PMID: 36674721
Ali et al (2017) Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1. BMC Cancer 17 803 PMID: 29187162
Do you know of a great paper that uses Letrozole from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Letrozole and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image